Dapsone and Zenapax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dapsone (dapsone) and Zenapax (daclizumab). Common drug interactions include oesophageal spasm among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Dapsone and Zenapax. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.

What is Zenapax?

Zenapax has active ingredients of daclizumab. eHealthMe is studying from 1,314 Zenapax users. Check the latest studies of Zenapax.



On Aug, 07, 2026

13 people who take Dapsone and Zenapax together, and have interactions are studied.

Dapsone and Zenapax drug interactions.

What are the common drug interactions of Dapsone and Zenapax, by gender? *:

female:

  1. Oesophageal spasm (contraction of oesophagus)

male:

  1. Blood creatinine increased
  2. Venous thrombosis deep limb (blood clot that forms in a vein deep in the limb)
  3. Blood glucose increased
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Oedema peripheral (superficial swelling)
  7. Pain
  8. Swelling
  9. Atelectasis (partial or complete collapse of the lung)
  10. Biliary tract disorder

What are the common drug interactions of Dapsone and Zenapax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood creatinine increased
  2. Venous thrombosis deep limb (blood clot that forms in a vein deep in the limb)
  3. Oesophageal candidiasis (fungal infection of oesophagus)
  4. Anaemia (lack of blood)
  5. Haematocrit decreased
  6. Oedema lower limb (fluid collection in tissue of lower leg)
  7. Chest pain
  8. Dyspnoea (difficult or laboured respiration)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

50-59:

n/a

60+:

  1. Oedema peripheral (superficial swelling)
  2. Pain
  3. Viral infection
  4. Alanine aminotransferase increased
  5. Aspartate aminotransferase increased
  6. Blood alkaline phosphatase increased
  7. Blood pressure diastolic decreased
  8. Blood sodium decreased
  9. Body temperature increased
  10. Crepitations (noises are produced by the rubbing of parts one against the other)

What are the existing conditions these people have? *

  1. Kidney Transplant Rejection: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Dapsone and Zenapax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dapsone and Zenapax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zenapax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dapsone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zenapax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dapsone and daclizumab (the active ingredients of Dapsone and Zenapax, respectively), and Dapsone and Zenapax (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: